Eprosartan Reduces Inflammation and Oxidative Stress in Ethanol-induced Hepatotoxicity
Our results revealed that the pre-treatment with Eprosartan (60 mg/kg) preserves against chronic alcohol-induced hepatic damage.
Authors
- Mohammad Bagher Jahantab
- Mahboubeh Mansourian (ORCID: https://orcid.org/0000-0001-5419-2026)
- Sadrollah Mehrabi (ORCID: https://orcid.org/0000-0001-8481-9205)
- Mahdokht Azizi
- Rozina Abbasi Larki (ORCID: https://orcid.org/0000-0003-4908-8886)
- Ali Taheri Mirghaed (ORCID: https://orcid.org/0000-0001-5568-1390)
- Hamid Behrouj
- Gholamreza Daryabor (ORCID: https://orcid.org/0000-0001-5473-2491)
- Farzaneh Karimi (ORCID: https://orcid.org/0000-0002-1112-3191)
- Amir Hossein Doustimotlagh
- Soroor Abdzadeh
Institutions
- Shiraz University of Medical Sciences (IR)
- Yasuj University of Medical Sciences (IR)
Publication Details
- Journal
- Current Pharmaceutical Design
- Published
- 2025-02-13
- DOI
- https://doi.org/10.2174/0113816128342059250122060526
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00